glutathione switch persister cells Cancer drug-tolerant cells: from biological questions to clinical opportunities Low-GPX4 drives a sustained drug-tolerant
Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect Targeting of vulnerabilities of drug tolerant persisters identified through functional genetics delays tumor relapse: Cell Reports Medicine Tolerant Persister Cancer Cells and the Path to Resistance to Targeted Therapy Glutathione synthesis: A two step pathway. Homeostasis of cellular Download Scientific Diagram
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


